Literature DB >> 20178827

Glucocorticoid up-regulates mimecan expression in corticotroph cells.

Qin-Yun Ma1, Chun-Lin Zuo, Jun-Hua Ma, Xiao-Na Zhang, Ying Ru, Ping Li, Chun-Ming Pan, Zhi Liu, Huang-Ming Cao, Ming-Dao Chen, Huai-Dong Song.   

Abstract

Mimecan is a protein of unknown function that is expressed in the pituitary. The aim of this study is to clarify the regulation and intracellular localisation of mimecan gene expression in the pituitary. With immunohistochemistry, we observed that mimecan protein was co-expressed with ACTH in pituitary corticotroph cells. Northern and Western blot analyses revealed that mimecan expression and secretion in corticotroph cells were up-regulated by treating AtT-20 cells with glucocorticoid. Meanwhile, mimecan expression in rat primary culture pituitary cells was also promoted by glucocorticoid. Co-incubation of AtT-20 cells with RU486 and glucocorticoid completely reversed the induction of mimecan gene expression by glucocorticoid. In addition, luciferase reporter assays showed that the -1474/+43 promoter region of mimecan was sufficient for glucocorticoid-responsive mimecan expression. These data collectively suggest that mimecan expressed in pituitary corticotroph cells is increased by glucocorticoid and that the up-regulation may be mediated by the classical GR pathways. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178827     DOI: 10.1016/j.mce.2010.02.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  The mechanism of mimecan transcription induced by glucocorticoid in pituitary corticotroph cells.

Authors:  Xiao Na Zhang; Li Qiong Xue; He Jiang; Shao Ying Yang; Huai Dong Song; Qin Yun Ma
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

Review 2.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

3.  Mimecan, a Hormone Abundantly Expressed in Adipose Tissue, Reduced Food Intake Independently of Leptin Signaling.

Authors:  Huang-Ming Cao; Xiao-Ping Ye; Jun-Hua Ma; He Jiang; Sheng-Xian Li; Rong-Ying Li; Xue-Song Li; Cui-Cui Guo; Zhi-Quan Wang; Ming Zhan; Chun-Lin Zuo; Chun-Ming Pan; Shuang-Xia Zhao; Cui-Xia Zheng; Huai-Dong Song
Journal:  EBioMedicine       Date:  2015-09-28       Impact factor: 8.143

4.  Tumor-suppressive function of UNC5D in papillary thyroid cancer.

Authors:  Man-Man Zhang; Feng Sun; Bing Cui; Le-Le Zhang; Ya Fang; Yan Li; Rui-Jia Zhang; Xiao-Ping Ye; Yu-Ru Ma; Bing Han; Huai-Dong Song
Journal:  Oncotarget       Date:  2017-10-10

5.  Serum osteoinductive factor is associated with microalbuminuria and diabetic nephropathy in type 2 diabetes.

Authors:  Wen Wei; Mei Tu; Rong Huang; Tong Chen
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.